back to overview


TytoCare closes $50 million round as the demand for telehealth accelerates

April 09, 2020 + Jessica Di Palo
5 Min read

The $50 million round will support the TytoCare to continue to scale business activities globally, as well as respond to the increase in demand for their digital health solutions.

Tytocare closes investment round

MTIP, the pan-European specialist Healthtech investor, took part in the newest financing round for Fund I Portfolio Company TytoCare. The $50 million round will support the Company to continue to scale business activities globally, as well as respond to the increase in demand for their digital health solutions.

In these troubling times caused by COVID-19, when we all face social isolation and governments impose restrictions upon us, we need to constantly monitor these impacts on our selected portfolio companies. As the demand for telehealth is accelerating, we are proud that TytoCare, the healthcare industry’s first all-in-one modular device and telehealth platform for on-demand, remote medical examinations, closed a financing round of $50 million, bringing the Company’s total capital raised to more than $105 million.

TytoCare’s product TytoHomean easy to use toolkit that offers on-demand medical exams for patients, is a unique telehealth diagnostic solution. The Israeli digital health Company allows patients to selfmonitor, and the data to be sent remotely to physicians, allowing them to oversee patients without exposure to a disease. In Switzerland the health inscurance Company SWICA will be testing TytoHome with 2000 of their customers until the end of 2020. The insurer reports that their pilot project has been very popular and that all devices have been successfully assigned. 

«This round of financing will allow Tyto Care to focus even more on the needs of patients to develop new devices that build on their telehealth platform», said Dr. Christoph Kausch Managing Partner of MTIP. He adds: «Furthermore, we see the Company’s development as a confirmation of our investment thesis». MTIP recognized several years ago that the system was not able to keep up with demand, and the healthcare sector would need to innovate and leverage new technologies to continue to operate at a sustainable level. One of the key pillars of MTIP’s investment thesis is the need for decentralizationIn an environment where we are all isolated in our homes, it is companies like TytoCare that are of particular necessity. MTIP is confident in the defensiveness of the Healthtech sector and our ability to continue to make successful investments throughout the cycle. It is with great pleasure that we look back on the previous relationship between TytoCare and MTIP and look forward to how this symbiosis will continue to grow in the future.

As TytoCare CEO and Co-founder Dedi Gilad noted: «MTIP has played and will continue to play a vital role in opening doors and creating potential partnerships throughout EuropeBuilding on the success and excitement for TytoCare in the US, we are pleased to be partnering with such a knowledgeable digital health investor whose unique position will help us further transform telehealth and reach more homes around the globe, especially in Europe.»

Share the Article


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II


How to pitch to a healthtech Investor

Blog Pitching


MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health


MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020


4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour


MTIP invests in Trialbee

New investment in Trialbee


TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round


The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April


MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020


New MTIP investment in Oviva

New investment in Oviva


Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper


Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch

Elite Summit 2019


MTIP Healthcare Clinic 2019

Healthcare clinic 2019

New MTIP investment in Cynerio

New investment in Cynerio


MTIP invests in Lumeon Ltd.

New investment in Lumeon

Magenverkleinerung mit der Handnähmaschine

Nitinotes news paper article


New MTIP investment in Quanta Dialysis Technologies

New investment in Quanta